BAP1 PLAYS A SURVIVAL ROLE IN CUTANEOUS MELANOMA

por Kumar, Raj, Taylor, Michael, Miao, Benchun, Ji, Zhenyu, Njauw, Jenny Ching-Ni, Jönsson, Göran, Frederick, Dennie Tompers, Tsao, Hensin
Publicado en J Invest Dermatol (2014)

Mixed Response to Immunotherapy in Patients with Metastatic Melanoma

por Rauwerdink, Daan Jan Willem, Molina, George, Frederick, Dennie Tompers, Sharova, Tanya, van der Hage, Jos, Cohen, Sonia, Boland, Genevieve Marie
Publicado en Ann Surg Oncol (2020)

Low expression of the PPARγ-regulated gene thioredoxin-interacting protein accompanies human melanoma progression and promotes experimental lung metastases

por Meylan, Patrick, Pich, Christine, Winkler, Carine, Ginster, Stefanie, Mury, Lionel, Sgandurra, Marie, Dreos, René, Frederick, Dennie Tompers, Hammond, Marc, Boland, Genevieve Marie, Michalik, Liliane
Publicado en Sci Rep (2021)

BCL2A1 is a lineage-specific antiapoptotic melanoma oncogene that confers resistance to BRAF inhibition

por Haq, Rizwan, Yokoyama, Satoru, Hawryluk, Elena B., Jönsson, Göran B., Frederick, Dennie Tompers, McHenry, Kevin, Porter, Dale, Tran, Thanh-Nga, Love, Kevin T., Langer, Robert, Anderson, Daniel G., Garraway, Levi A., Duncan, Lyn McDivitt, Morton, Donald L., Hoon, Dave S. B., Wargo, Jennifer A., Song, Jun S., Fisher, David E.
Publicado 2013

BRAF Inhibition Increases Tumor Infiltration by T cells and Enhances the Anti-tumor Activity of Adoptive Immunotherapy in Mice

por Liu, Chengwen, Peng, Weiyi, Xu, Chunyu, Lou, Yanyan, Zhang, Minying, Wargo, Jennifer A., Chen, Jie Qing, Li, Haiyan S., Watowich, Stephanie S., Yang, Yan, Frederick, Dennie Tompers, Cooper, Zachary A., Mbofung, Rina M, Whittington, Mayra, Flaherty, Keith T., Woodman, Scott E., Davies, Michael A., Radvanyi, Laszlo G., Overwijk, Willem W., Lizée, Gregory, Hwu, Patrick
Publicado 2012

BRAF inhibition is associated with enhanced melanoma antigen expression and a more favorable tumor microenvironment in patients with metastatic melanoma

por Frederick, Dennie Tompers, Piris, Adriano, Cogdill, Alexandria P., Cooper, Zachary A., Lezcano, Cecilia, Ferrone, Cristina R., Mitra, Devarati, Boni, Andrea, Newton, Lindsay P., Liu, Chengwen, Peng, Weiyi, Sullivan, Ryan J, Lawrence, Donald P., Hodi, F. Stephen, Overwijk, Willem W., Lizée, Gregory, Murphy, George F., Hwu, Patrick, Flaherty, Keith T., Fisher, David E., Wargo, Jennifer A.
Publicado 2013

Tumor-associated B-cells induce tumor heterogeneity and therapy resistance

por Somasundaram, Rajasekharan, Zhang, Gao, Fukunaga-Kalabis, Mizuho, Perego, Michela, Krepler, Clemens, Xu, Xiaowei, Wagner, Christine, Hristova, Denitsa, Zhang, Jie, Tian, Tian, Wei, Zhi, Liu, Qin, Garg, Kanika, Griss, Johannes, Hards, Rufus, Maurer, Margarita, Hafner, Christine, Mayerhöfer, Marius, Karanikas, Georgios, Jalili, Ahmad, Bauer-Pohl, Verena, Weihsengruber, Felix, Rappersberger, Klemens, Koller, Josef, Lang, Roland, Hudgens, Courtney, Chen, Guo, Tetzlaff, Michael, Wu, Lawrence, Frederick, Dennie Tompers, Scolyer, Richard A., Long, Georgina V., Damle, Manashree, Ellingsworth, Courtney, Grinman, Leon, Choi, Harry, Gavin, Brian J., Dunagin, Margaret, Raj, Arjun, Scholler, Nathalie, Gross, Laura, Beqiri, Marilda, Bennett, Keiryn, Watson, Ian, Schaider, Helmut, Davies, Michael A., Wargo, Jennifer, Czerniecki, Brian J., Schuchter, Lynn, Herlyn, Dorothee, Flaherty, Keith, Herlyn, Meenhard, Wagner, Stephan N.
Publicado en Nat Commun (2017)